Jiangsu Hengrui | 600276 - Ebit

Stock Price
55.27
Daily Change
-0.78 -1.39%
Monthly
-0.88%
Yearly
10.61%
Q2 Forecast
54.92

Jiangsu Hengrui reported CNY2.56B in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Kangmei Pharma CNY -26.7M 43.13M Sep/2025
Sh Fosun Pharma CNY 864.14M 185.2M Dec/2025
Sh Pharmaceutical CNY 1.88B 283.52M Dec/2025
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Wuxi Apptec CNY 4.67B 73.59M Dec/2025
Zz Pientze Pharmaceu CNY 501.33M 15.6M Sep/2025